NDC 0002-3233-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-3233
- Requested NDC
- 0002-3233-01
- Package NDCs from labels
- 0002-3233-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-11 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-3233-01 | EA - Each | 0002-3233 | a1a40876-81b2-4d1b-ac9f-5ea7ff8f9c6e | 1 | 2013-02-11 |
| 0002-3233-30 | EA - Each | 0002-3233 | 4f610fcf-b8fb-4971-947a-5180e798ea92 | 1 | 2012-07-24 |
| 0002-3233-33 | EA - Each | 0002-3233 | 59932593-2657-4558-a765-db58b745f9a8 | 1 | 2013-02-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | American Health Packaging | c0d705bf-b719-4c7b-b83d-c17d41cbbfad | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Sandoz Inc | 1e9666ef-4271-4834-8496-ccb3125d83db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| OLANZAPINE | OLANZAPINE | Eugia US LLC | 9c745e2e-89d3-44d4-906e-704705c33310 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | A-S Medication Solutions | 2c56a437-f6bf-4ac8-b1d9-fc8a605a97e7 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | A-S Medication Solutions | 3e6b9d55-f9bb-4bf2-bc6c-975cc0d94d23 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Evista | RALOXIFENE HYDROCHLORIDE | Eli Lilly and Company | fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | Eli Lilly and Company |
| Olanzapine | OLANZAPINE | Aurobindo Pharma Limited | 636665be-9d7e-443a-8134-e8cc47e6ba24 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| Olanzapine | OLANZAPINE | Coupler LLC | 495efc49-7cdb-4b9e-e063-6394a90a547e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | OLANZAPINE |
| TALTZ | IXEKIZUMAB | Eli Lilly and Company | ac96658a-d7dc-4c7c-8928-2adcdf4318b2 | 2026-01-22 | Warnings, Adverse reactions | Eli Lilly and Company |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Aurobindo Pharma Limited | 45454555-7402-41cb-a452-e6a76e04f387 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Reyvow | LASMIDITAN | Eli Lilly and Company | aea3358c-ff41-4490-9e6d-c7bf7b3de13f | 2026-01-08 | Warnings, Adverse reactions | Eli Lilly and Company |
| Prozac | FLUOXETINE HYDROCHLORIDE | Dista Products Company | c88f33ed-6dfb-4c5e-bc01-d8e36dd97299 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine Hydrochloride | FLUOXETINE HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | 1ffe57c3-6f70-4075-aacb-d87a3990fdea | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Northwind Health Company, LLC | da6b9b19-2ea1-9a39-e053-2995a90ad730 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Northwind Health Company, LLC | dfae4357-b6f9-9a30-e053-2995a90a2667 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Northwind Health Company, LLC | aae4e339-5244-f6f9-e053-2995a90a42ce | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| Fluoxetine | FLUOXETINE HYDROCHLORIDE | Northwind Health Company, LLC | ab1eec9d-f755-81a2-e053-2a95a90acb3c | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | FLUOXETINE HYDROCHLORIDE |
| TAUVID | FLORTAUCIPIR F-18 | Eli Lilly and Company | b483abad-5230-462a-adfb-1a65160f01d0 | 2025-12-30 | Warnings, Adverse reactions | Eli Lilly and Company |
| Kisunla | DONANEMAB-AZBT | Eli Lilly and Company | 190352d4-ef62-4679-b4fa-e846e2766afa | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | Eli Lilly and Company |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.